Curing cancer with Cannabidiol?
- CANNABIS OIL, NEWS
- April 24, 2013

In a major federal appeals court decision, Florida medical cannabis patients won a significant victory for Second Amendment rights. On August 20, 2025, the Eleventh Circuit Court of Appeals ruled that individuals registered with Florida’s medical marijuana program cannot be automatically denied the right to purchase or possess firearms solely based on their medicinal cannabis
READ MORE
As meditation gains traction as a remedy for stress and a path to emotional balance, many are seeking ways to enrich their practice. Recent research highlights CBD oil—a non-psychoactive compound derived from hemp—as a promising adjunct. Unlike THC, CBD does not intoxicate, giving users relaxation without impairment. CBD interacts with the endocannabinoid system to regulate
READ MORE
Texas has broadened its medical cannabis program, allowing more patients with chronic pain and serious conditions to qualify for treatment under the state’s low-THC framework. Unlike recreational markets, Texas restricts products to less than 0.5% THC and limits prescribing to registered physicians, with dispensing tightly regulated. Patients won’t find smokable flower; instead, approved options include
READ MORE
CBD oil, derived from hemp and cannabis, has become a prominent natural remedy for anxiety, pain, inflammation, and sleep issues. As explained in a recent Lusaka Times guide, CBD is non-intoxicating and works by supporting the body’s endocannabinoid system, which helps regulate mood, sleep, and pain. Products range from isolates (just CBD) to full-spectrum oils
READ MORE
Medical cannabis is gaining traction for treating a diverse range of health conditions, bolstered by loosening regulations and evolving medical research. As of August 2025, the Drug Enforcement Administration (DEA) is moving toward reclassifying marijuana from a Schedule I to a Schedule III drug, although the process remains incomplete. Despite ongoing federal restrictions, cannabis is
READ MORE
A new bill introduced in Pennsylvania aims to require employers to reimburse injured workers for medical cannabis prescribed under the state’s medical marijuana program. Sponsored by Rep. David Delloso (D), the proposal would cover up to $250 per month and a maximum of $3,000 annually for qualifying patients, offering an alternative to opioids for pain
READ MORE